Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedTwo editorial updates were made: the Publications note wording changed slightly, and the page revision tag was updated from v3.2.0 to v3.3.2. These are minor updates and do not affect study data or results.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded Tainan, Taiwan to the Locations section and replaced Tainan City, Taiwan. Removed the funding-status notice about government funding at the top of the page.SummaryDifference0.3%

- Check32 days agoChange DetectedThe study details appear unchanged between the two screenshots. No substantive edits to core information such as study status, design, eligibility criteria, or endpoints are visible.SummaryDifference0.3%

- Check60 days agoChange DetectedUpdated operating status notice and version to v3.2.0, replacing v3.1.0.SummaryDifference4%

- Check68 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check82 days agoChange DetectedVersion update: v3.0.2 replaces v3.0.1, and the 'Back to Top' element was removed; overall, this is a minor UI change with no core content changes.SummaryDifference0.2%

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.